Next Article in Journal
Incidence and Impact of Myocarditis in Genetic Cardiomyopathies: Inflammation as a Potential Therapeutic Target
Previous Article in Journal
Comparative Analysis of Complete Chloroplast Genomes and Phylogenetic Relationships of 21 Sect. Camellia (Camellia L.) Plants
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Genetic Determinants of Listeria monocytogenes Resistance to Bacteriocins Produced by Lactic Acid Bacteria

by
Anna Zawiasa
and
Agnieszka Olejnik-Schmidt
*
Department of Food Biotechnology and Microbiology, Poznan University of Life Sciences, Wojska Polskiego 48, 60-627 Poznan, Poland
*
Author to whom correspondence should be addressed.
Genes 2025, 16(1), 50; https://doi.org/10.3390/genes16010050
Submission received: 10 December 2024 / Revised: 24 December 2024 / Accepted: 29 December 2024 / Published: 3 January 2025
(This article belongs to the Section Microbial Genetics and Genomics)

Abstract

:
Background: Listeria monocytogenes is a Gram-positive bacterium responsible for listeriosis, a serious foodborne disease that can lead to serious health complications. Pregnant women, newborns, the elderly, and patients with weakened immune systems are particularly susceptible to infection. Due to the ability of L. monocytogenes to survive in extreme environmental conditions, such as low temperatures, high salinity, and acidity, this bacterium poses a serious threat to food production plants and is particularly difficult to eliminate from these plants. One of the promising solutions to reduce the presence of this bacterium in food products is bacteriocins as natural control agents. These are substances with antibacterial activity produced by other bacteria, mainly lactic acid bacteria (LAB), which can effectively inhibit the development of pathogens such as L. monocytogenes. The use of bacteriocins in the food industry is beneficial due to their natural origin, specificity of action, and consumer safety. However, the problem of resistance to these substances exists. Results: This review focuses on the mechanisms of bacteriocin resistance, such as modifications of bacteriocin docking receptors, changes in the structure of the cell wall and membrane, and the occurrence of cross-resistance to different bacteriocins. Genetic factors determining these mechanisms and strategies to cope with the problem of resistance are also presented. Conclusions: Research on this issue is crucial for developing effective preventive methods that will enable the safe and long-term use of bacteriocins in food production.

1. Introduction

The genus Listeria is an important group of microorganisms in the food industry, now consisting of 27 officially recognized species. Based on recent findings, the genus has been divided into two clades: Listeria sensu stricto, which includes L. monocytogenes and species closely related to it, and Listeria sensu lato, which encompasses species that are more distantly related to L. monocytogenes [1]. L. monocytogenes is pathogenic in both humans and animals [2]. On rare occasions, other Listeria species, such as L. ivanovii, L. seeligeri, and L. innocua, have been associated with human diseases [3,4]. Listeria spp. such as L. innocua are frequently employed as indicators of favorable conditions for the growth of L. monocytogenes [5,6].
L. monocytogenes is a Gram-positive, rod-shaped, and facultative anaerobic bacterium [1,7]. This bacterium is ubiquitous in the agricultural environment and has been found in soil, water, plants, and animals. L. monocytogenes has extraordinary adaptive abilities and can survive in extreme conditions that typically function to inhibit the proliferation of bacteria, such as the temperature range from 45 °C to −1.5 °C, which allows growth at refrigeration temperatures [8,9]. In addition, this bacterium has the ability to proliferate over a wide pH range (4.4–9.6), low water activity (aw < 0.90), and high salt concentration (even 20%) and in the presence of disinfectants and preservatives [9,10]. Furthermore, L. monocytogenes can form biofilms on both living and inanimate surfaces, protected from disinfectants, which further increases its ability to survive under difficult conditions [11]. However, it is unable to withstand pasteurization temperatures, which is why contamination in food processing plants typically occurs during post-pasteurization processes [11,12,13]. This causes L. monocytogenes to persist in food production plants, enter the food chain, and lead to contamination of many food products [13], such as raw and processed meat [8,14], fish, unpasteurized milk and dairy products, raw fruit and vegetables and ready-to-eat products [15,16,17]. The main route of spread of L. monocytogenes to humans is the intake of highly contaminated food [18], with foodborne transmission accounting for as much as 99% [4,13,19]. From these points of view, managing L. monocytogenes during industrial food processing presents significant challenges [19,20].
L. monocytogenes is the causative agent of a serious foodborne illness called listeriosis [17,21]. The symptoms of listeriosis are influenced by many factors, such as infectious dose, age, immune status of the consumer, and strain virulence [21,22]. This disease can manifest in invasive or non-invasive forms [23]. For individuals with a healthy immune system, a non-invasive form of listeriosis develops [22,24] and can lead to mild gastroenteritis symptoms such as nausea, vomiting, diarrhea, and fever [2,24]. In immunocompetent people, diseases are self-limiting, often resolved without the need for medical attention, resulting in undiagnosed cases and underreporting [8]. An invasive form of listeriosis develops in susceptible people, such as pregnant women, newborns, and the elderly, as well as people with weakened immune systems, such as those who have received organ transplants. In these groups, listeriosis can lead to life-threatening symptoms such as sepsis, bacterial meningitis [14], or brain infections [25]. In pregnant women, it can cause mother-to-fetus infections, resulting in spontaneous abortion, stillbirth, or premature birth [11,25,26]. Generally, listeriosis causes high hospitalization rates (95%) [26] and high mortality rates, reaching 20–30% [27]. In contrast, infection with other common foodborne illnesses, such as campylobacteriosis and salmonellosis, seldom leads to deaths [26,27,28,29,30]. For this reason, L. monocytogenes has been classified as one of the four foodborne pathogens considered the most significant threat to public health by the World Health Organization (WHO) since the early 1980s [31,32].
L. monocytogenes has several molecular mechanisms that allow it to adapt throughout the various stages of its pathogenic lifecycle [33]. The transition to an intracellular lifestyle for pathogens involves an upregulation of gene products that facilitate cell-to-cell spread and enhance bacterial replication within the host’s cytosol [17,34]. After ingestion of contaminated food, L. monocytogenes must survive exposure to tough conditions in the host system, e.g., high acidity and bile salts. Surviving these conditions is crucial to the pathogenesis of this bacteria. Moreover, L. monocytogenes has the ability to cross three critical barriers in the human body: the intestinal epithelium, the blood–brain barrier, and the placenta [35]. After binding to the epithelial cells of the gastrointestinal tract with the help of the internalin proteins InlA and InlB (encoded by inlA and inlB), L. monocytogenes is engulfed by macrophages within an initial phagosomal vacuole [8]. Once inside, L. monocytogenes escapes from the membrane-bound vacuole by secreting a pore-forming cytolysin called listeriolysin O (LLO) (encoded by hly), along with two phospholipases (encoded by plcA and plcB) that collectively dismantle the phagosome where the bacteria reside. Inside the cytosol of the host cell, the bacteria replicate by utilizing nutrients sourced from the host [33]. L. monocytogenes then moves through the cytoplasm and invades neighboring cells, utilizing actin polymerization as a means of motility, which is directed by its surface protein actin assembly-inducing protein (ActA) (encoded by actA) [33]. All gene products involved in bacterial invasion, cytosolic entry, growth, intracellular movement, and spread to neighboring cells are regulated by the transcriptional regulator PrfA [34]. The most important virulence determinants are clustered in the chromosome in pathogenicity islands, such as Listeria pathogenicity island 1 (LIPI-1), LIPI-3 and LIPI-4 [8,35].
The incidence of listeriosis in Europe has been rising in recent years [36,37,38]. Significant shifts in food production, processing, and distribution practices, along with the growing reliance on refrigeration as a primary method of preservation; alterations in dietary habits, especially an increased consumption of ready-to-eat (RTE) foods [38,39]; and demographic changes, such as a rise in the population at higher of for the disease because of aging are all proposed as potential factors contributing to the emergence of human foodborne listeriosis [40].
Due to these factors, many countries, including the USA, enforce a strict zero-tolerance policy regarding the presence of L. monocytogenes in RTE foods. In contrast, the European Regulation on Microbiological Criteria for Foodstuffs No. 2073/2005 sets forth two different standards for L. monocytogenes in RTE foods based on considerations such as pH, water activity, and bacterial growth potential. One standard applies to RTE foods for infants and special medical purposes, banning L. monocytogenes in 25 g of food, while the other allows up to 100 cfu/g in RTE foods not intended for those purposes throughout the product’s shelf life [41]. This highlights the need for the industry to use precise and reliable methods to detect L. monocytogenes in food products [2].
In recent times, several techniques for detecting Listeria spp., including L. monocytogenes, in food have been developed. Advances in diagnostic technologies allow for more accurate and faster detection of L. monocytogenes bacteria. This means that more cases are identified, which increases the number of reported cases [42]. These methods can be divided into two main groups: conventional methods, such as culture-based techniques, and alternative methods [2,4]. Food laboratories commonly use conventional microbiological techniques for detecting Listeria spp., following guidelines from organizations such as the U.S. Food and Drug Administration (FDA) and the International Organization for Standardization (ISO). These methods include standards such as EN ISO 11290-1:2017 [43] and EN ISO 11290-2:2017 [44], which involve steps such as pre-enrichment and enrichment in selective or differential media, such as Listeria Agar Ottaviani and Agosti (ALOA), Oxford, or PALCAM, followed by biochemical analysis, e.g., β-hemolysis test [4,12]. Traditional culture-dependent methods remain the gold standard; however, they are time-intensive and significantly dependent on the phenotype that is subject to different environmental conditions [2]. Consequently, faster alternative methods have emerged, employing various approaches. These include molecular techniques, such as polymerase chain reaction (PCR) and its variations, such as multiplex PCR and real-time PCR (RT-PCR), based on the detection of species-specific DNA sequences, including 16S rRNA genes and virulence genes, as well as immunological methods, which rely on antigen–antibody interactions, such as enzyme-linked immunosorbent assay (ELISA), along with microarrays and biosensors [1].
Due to the fact that there are many strains of L. monocytogenes, further subtyping is necessary. Conventional subtyping methods include serotyping. L. monocytogenes strains can be recognized by specific combinations of somatic (O) and flagellar (H) antigens present on their cell surfaces [35]. As of today, L. monocytogenes consists of four lineages (I, II, III, and IV) and 14 serotypes. Lineage I includes strains classified under serotypes 1/2b, 3b, 4b, 4d, 4e, 4h, and 7, while lineage II consists of strains belonging to serotypes 1/2a, 1/2c, 3a, and 3c. Lineage III encompasses strains from serotypes 4a and some 4b and 4c strains, whereas some 4a, 4b, and 4c strains have been characterized into lineage IV [8]. However, 95% of isolates obtained from food and clinical cases of listeriosis in humans belong to three of these serotypes: 4b, 1/2a and 1/2b. This indicates that certain serotypes may exhibit higher virulence or a greater ability to adapt to the human host [45,46]. More interestingly, serotype 1/2a is the most commonly isolated from food, while serotype 4b is primarily responsible for listeriosis infections [45,47]. For the serotyping of L. monocytogenes, both standard agglutination methods with mono-/polyvalent antisera [16] and PCR-based genoserotyping methods can be used [43]. Other L. monocytogenes subtyping methods include methods based on the use of restriction enzymes, such as pulsed-field gel electrophoresis (PFGE), and subtyping methods based on PCR, such as random amplified polymorphic DNA (RAPD) or multilocus sequence typing (MLST) [2]. Despite the great diversity of virulence of L. monocytogenes serotypes, in the European Union, including Poland, there is no obligation to identify the serotypes of this bacterium [46].

2. Resistance to Stresses Associated with Food Production

As mentioned above, L. monocytogenes, as a non-spore-forming pathogen, has remarkable adaptive abilities to food stresses [10]. The key role in the stress response is played by the two-component systems, such as LiaRS, LisRK, CesRK, AgrCA, and VirRS, controlled by σB (SigB), an alternative sigma factor that controls the general stress response in L. monocytogenes [47]. L. monocytogenes’ exceptional ability to withstand stressful conditions makes it a serious challenge in food processing and an ideal model organism for studying resistance mechanisms to stress factors found in food and food production environments. In this review, we will touch on the mechanisms of resistance to common stresses occurring in food processing plants, such as high and low temperatures, acidic pH, and osmolarity, and we will primarily concentrate on the genetic factors and mechanisms underlying L. monocytogenes’ susceptibility and resistance to less-studied stress conditions, such as bacteriocins.
Thermal treatment is a widely used and effective method for eliminating foodborne pathogens, as most are highly sensitive to elevated temperatures. However, it is important to note that the effectiveness of thermal treatments against L. monocytogenes is reduced due to its ability to survive and reproduce within a broad temperature range, from −0.4 °C to 45 °C [48]. The heat resistance of L. monocytogenes is influenced by various factors, including prior environmental stresses, the food matrix, and internal characteristics such as serotypes. Previous studies [49,50] have shown that strains of serotype 1/2a, the most prevalent in food, demonstrated relatively low heat tolerance, whereas serotype 4b strains, which are linked to human listeriosis, showed significant variability in their response to heat. The highest heat tolerance was observed in serotype 7 strain [49,51]. At the molecular level, L. monocytogenes reacts to heat treatment by expressing genes associated with specific heat shock responses, such as the production of heat shock proteins (HSPs) [52]. Class I heat shock genes, such as dnaK, dnaJ, grpE, groEL, and groES, produce heat shock proteins that act as chaperones to prevent the misfolding of proteins that can occur during environmental stress. These genes are controlled by the negative regulator HrcA [52]. Class II HSP genes encode general stress proteins that are regulated by the alternative sigma factor SigB under various growth-inhibiting conditions [53]. Additionally, class III heat shock genes encode ATP-dependent proteases, including ClpC, ClpP, and ClpE, controlled by the gene regulator CtsR. Class III is essential for degrading misfolded proteins under stress conditions such as elevated temperatures [52].
Equally dangerous seems to be the resistance of L. monocytogenes to low, refrigerated temperature treatment. More concerning is the observation that the population of L. monocytogenes remained unchanged during freezing [53]. Resistance to low temperatures is provided by several mechanisms. First of all, L. monocytogenes diminished metabolic functions by reducing intracellular enzyme activity to the essential minimum and modifying the expression of genes associated with the biosynthesis of nutrients, including lipids, carbohydrates, and amino acids, as well as those related to motility [54,55]. Furthermore, L. monocytogenes alters its membrane lipid composition by increasing the concentration of unsaturated fatty acids, thereby achieving optimal membrane fluidity for transport across the membrane [49,56]. Other adaptation mechanisms of L. monocytogenes to low temperatures have also been documented. One example of this mechanism is the expression of cold shock proteins called Csps [55]. Csps are small proteins, acting as chaperones, responsible for supporting essential life processes in bacteria [57]. Finally, L. monocytogenes increases the accumulation of cryoprotective substances such as carnitine, glycine betaine, and proline betaine [49]. Chan et al. [54] showed increased activity of L. monocytogenes at refrigeration temperature compared to human body temperature. The opuCABCD operon encodes a carnitine transporter, and gbuC encodes the binding protein of a glycine betaine transporter. These substances, which also function as osmolytes, have been found to play a role in osmotic stress resistance in L. monocytogenes. They help maintain proper turgor pressure and protect enzymes from degradation [49]. The study by Schmid et al. [57] also confirmed the involvement of Csps in the repair of DNA damaged by high concentrations of NaCl. These studies show the occurrence of simultaneous resistance to different stresses. The mechanism seems to further increase the problem of L. monocytogenes persistence in food processing plants.
Another challenge faced by L. monocytogenes in food processing is acidification, which occurs during fermentation by lactic acid bacteria (LAB). These bacteria are naturally present in food, originating from raw materials, and are also intentionally introduced as starter cultures [58]. L. monocytogenes employs several mechanisms to regulate its internal pH when exposed to acid stress. The main mechanism involved in the protection of bacteria against acidification stress is the glutamic acid decarboxylase (GAD) system. This system is composed of three gene products—GadA, GadB, and GadC (encoded by three genes gadD1, gadD2, and gadD3)—that function by converting extracellular glutamate into γ-aminobutyrate (GABA) through an enzymatic reaction [59]. This mechanism helps protect the bacteria in environments where the pH drops below 4.5. Another protective strategy involves the arginine and agmatine deiminase pathways [60]. These systems play a key role in L. monocytogenes’ response to extreme acidity, helping to regulate internal pH by converting arginine into ammonium through a series of reactions. The low pH adaptation systems mentioned above function simultaneously to ensure the survival and adaptation of L. monocytogenes under acid-stress conditions [52].
L. monocytogenes has developed a range of mechanisms to withstand various stressors in food environments. It can deploy multiple strategies to combat the same type of stress or use a single mechanism to adapt to different stressors [48]. Biopreservation offers an alternative control measure for improving the stability and safety of food products. It reduces the number of chemical preservatives needed and the intensity of heat treatments, both of which can negatively affect food quality [61]. Using bacteriocins as biocontrol agents is a promising approach to managing pathogens like L. monocytogenes. Both Gram-positive and Gram-negative bacteria are capable of producing bacteriocins. Our main interest lies in the compounds synthesized by LAB [62].

3. Bacteriocins

LAB are part of a broad group of Gram-positive, microaerophilic microbes known for producing lactic acid as the primary byproduct of glucose fermentation in dairy products, fermented meat products, and fermented vegetables [58,63]. LAB consists of the following genera: Lactobacillus, Lactococcus, Pediococcus, Leuconostoc, Enterococcus, Streptococcus, Carnobacterium, and Weissella, and more peripheral genera such as Aerococcus, Tetragenococcus, and Oenococcus [58,64]. They have been used for centuries in the production of fermented foods due to their positive impact on nutritional value, sensory qualities, and shelf life [65]. This is due to the production of antimicrobial agents, including organic acids, carbon dioxide, ethanol, hydrogen peroxide, and bacteriocins, in particular [66,67].
Bacteriocins produced by LAB are ribosomally synthesized antimicrobial peptides that exhibit bactericidal or bacteriostatic activity against strains of closely related bacteria [64]. They are regarded as narrow-spectrum bacteriocins, although some bacteriocins have a broad spectrum of activity, including species unrelated to the producer, spoilage organisms, and food-borne pathogens such as L. monocytogenes [64,66]. Activity against Gram-negative bacteria has been demonstrated, but typically only when the outer membrane’s integrity is compromised. Bacteriocin-producing organisms are resistant to their own antimicrobial peptides, a defense mediated by specific immunity proteins [59]. Genes responsible for the synthesis of bacteriocins are grouped into gene operons, most often located on mobile genetic elements such as bacteriocinogenic plasmid. This opens up the possibility of bacteriocin synthesis in heterologous systems [66,68].
The first classification, created by Klaenhammer [69], included four classes of bacteriocins. Today, bacteriocins are divided into three major classes based on biological activity. Bacteriocins produced by LAB are mainly classified into classes I and II. Class I bacteriocins include small, post-translationally modified peptides called lantibiotics [64]. Bacteriocins of this class, as a result of post-translational modifications, acquire unusual amino acids such as lanthionine and/or methyllanthionine. The vast majority of class I bacteriocins are produced by Gram-positive bacteria belonging to the species of LAB. The most widely studied member of group I is nisin, produced by Lactococcus lactis. The biosynthesis of nisin is governed by an operon composed of 11 genes, regulated by the two-component NisRK system. This system functions as part of a quorum sensing (QS) mechanism, responding to the concentration of nisin [66].
Class II bacteriocins are small (<10 kDa), thermostable, unmodified peptides. The characteristic feature of this class of bacteriocins is their bactericidal activity against the pathogen L. monocytogenes. For this reason, class II bacteriocins are often called listericidal bacteriocins [70]. The structure of peptides of class IIa can be divided into two different regions separated by a flexible hinge. The cationic N-terminal region contains two cysteine residues joined by a disulfide bridge and a conserved YGNGVXC motif characteristic of bacteriocins of this class [71]. The C-terminus is less conserved. Both regions of the bacteriocin contribute to its bactericidal activity: the N-terminus is involved in interacting with the target cell, while the C-terminus determines the specificity of the target cell [71]. This class can be further divided into a few subclasses, namely subclass IIa (pediocin-like bacteriocins), subclass IIb (dipeptide bacteriocins), and subclass IIc (circular bacteriocins). The most well-known representative of class II bacteriocins is pediocin PA-1, which belongs to subclass IIa. Its gene operon is plasmid-encoded and consists of four genes: the structural gene pedA, the immunity gene pedB, and two additional genes, pedC and pedD, which encode an ABC transporter and an accessory protein, respectively [72]. Like nisin, pediocin PA-1 requires a specific receptor on the surface of the target cell for its bactericidal activity.
Class III bacteriocins are large, heat-sensitive protein molecules with molecular weights exceeding 30 kDa. Unlike other bacteriocins that remain stable at high temperatures, class III bacteriocins are prone to heat denaturation, which restricts their application in certain food processing scenarios. These bacteriocins function primarily by enzymatically degrading the cell walls of target bacteria, resulting in cell lysis. One example of a class III bacteriocin is helveticin J, which is produced by Lactobacillus helveticus [73]. The classification of bacteriocins is presented in Table 1.
Bacteriocins produced by LAB are of particular interest because many have a long history of safe use, and most LAB species are recognized as safe under the GRAS (Generally Recognized as Safe) and QPS (Qualified Presumption of Safety) classifications [66]. Bacteriocins can be utilized as natural preservatives, and with the increasing consumer preference for more natural products, they offer a promising alternative to chemical preservatives [72,75]. Bacteriocins possess numerous qualities that make them appealing as biopreservatives in food products. Defined as natural antimicrobial agents, they align with the increasing consumer preference for natural and minimally processed foods. Unlike many chemical preservatives, bacteriocins are non-toxic to humans; as protein compounds, they are degraded by proteolytic enzymes in the digestive system into simple, harmless components that are easily absorbed and metabolized. Due to their decomposition, they do not accumulate in the natural environment. As a result, they do not alter the composition of the gut microbiota and are non-cytotoxic and non-carcinogenic [74,78].
One significant advantage of bacteriocins over chemical preservatives or traditional sanitization methods is their selectivity and specific spectrum of action. They often display bactericidal activity against foodborne pathogens such as L. monocytogenes, Staphylococcus aureus, and Clostridium spp., while generally remaining inactive against starter cultures used in the fermentation of foods and probiotic microorganisms [71,72,73,75,79].

4. Mechanisms of Bacteriocin’s Action

Bacteriocins exhibit both bacteriostatic and bactericidal effects on bacterial cells. The mechanisms underlying the inhibitory actions of bacteriocins from LAB toward target cells exhibit a substantial diversity. The cationic nature of bacteriocins facilitates their docking onto anionic elements of the bacterial cell surface and interaction with the bacterial cell membrane or a specific membrane receptor [76,80]. In the next stage, bacteriocins induce permeabilization of the target bacterial cell membrane, which disrupts the proton motive force and depletes intracellular ATP, causing leakage of cell contents and, ultimately, cell death [77]. To date, seven receptors have been identified. The first to be identified and the most studied is lipid II. Lipid II, located in the cytoplasmic membrane, is pivotal in constructing the cell wall by transporting peptidoglycan monomers from inside to outside [77,81]. Lipid II is a crucial precursor targeted by nisin. Binding to lipid II, nisin disrupts cell wall synthesis and forms membrane pores, leading to bacterial cell death. Nisin also acts by blocking lipid II, inhibiting cell wall synthesis [81,82].
The second receptor is the mannose-specific phosphotransferase system (Man-PTS), the primary mannose transport system in Firmicutes and Gammaproteobacteria [80]. Man-PTS generally includes three proteins: enzyme I (EI), histidine phosphocarrier protein (HPr), and enzyme II (EII). EI and HPr, both cytoplasmic proteins, facilitate the transfer of a phosphate group to EII. EII comprises four subunits: IIA, IIB, IIC, and IID. IIA and IIB are found in the cytoplasm, while IIC and IID create a membrane-bound complex that allows sugar molecules to enter the cell [83,84]. The membrane subunits IIC and IID of Man-PTS are vital for the bactericidal effect of class IIa bacteriocins like pediocin PA-1 [66,83]. By binding to Man-PTS, pediocin-like bacteriocins cause cell membrane permeabilization, disrupt the proton motive force, and deplete ATP and intracellular substrates. This terminates all cellular biosynthesis, ultimately leading to cell death [84,85].
Other receptors include undecaprenyl pyrophosphate phosphatase UppP, the APC family amino acid transporter, CorC protein, ABC maltose transporter, and zinc-dependent metallopeptidase YvjB [80]. Receptor-dependent bacteriocins have a distinct, narrow range of activity, making them highly appealing for specific applications. Consequently, investigating receptor identification and bacteriocin-receptor interaction mechanisms is of paramount importance [80].

5. The Usefulness of Bacteriocins in Eliminating L. monocytogenes from Food

Bacteriocins produced by LAB are excellent for preserving food at risk of L. monocytogenes contamination. Especially promising is their potential to enhance the microbiological safety of minimally processed foods like dairy, meat, and various fruits and vegetables. Research has demonstrated that class IIa bacteriocins effectively reduce L. monocytogenes levels in many food products, making them a valuable tool in ensuring food safety [80,86].
Bacteriocins from different species of LAB have shown both bactericidal and bacteriostatic effects on L. monocytogenes. For instance, a starter culture of Pediococcus acidilactici producing pediocin PA-1 reduced L. monocytogenes in poultry sausages by up to 2.6 log cfu/g [87]. Similarly, pediocin PA-1 decreased L. monocytogenes in ripened cheese by up to 3 log cfu/g [88]. In cold-smoked, vacuum-packed salmon, bactericidal effects were noted for bacteriocins produced by Carnobacterium species. Piscicocin VIa and VIb, both produced by Carnobacterium piscicola V1, showed bactericidal activity, while divercin V41 from Carnobacterium divergens V41 demonstrated bacteriostatic activity [89]. Piscicolin 126, from Carnobacterium piscicola JG126, permanently reduced L. monocytogenes to undetectable levels in ham [80]. Additionally, saccacin P from Lactobacillus sakei Lb790 inhibited L. monocytogenes in vacuum-packed chicken slices, remaining stable on cold cuts for 4 weeks [90]; it also had bactericidal activity in cold-smoked salmon [91]. Enterocin A, produced by Enterococcus faecium strain CTC492, reduced L. monocytogenes by 1 log in dry fermented sausage and showed bactericidal activity when combined with enterocin B [90,92]. These studies demonstrate that bacteriocins, especially those from class IIa, are highly effective against L. monocytogenes, making them a powerful tool in food safety.
Bacteriocins can be incorporated into food through several methods and forms. One approach is to inoculate the food with a bacteriocin-producing strain [78]. Another option is to add purified bacteriocins as food additives [72]. Additionally, food can be processed using ingredients previously fermented with bacteriocin-producing strains. Bacteriocins may also serve as a component in bioactive packaging [80,93].
The use of bacteriocins in food is one of the dynamically developing areas of biopreservation. However, the number of bacteriocins widely used in the food industry remains limited. Despite the discovery and study of numerous bacteriocins, only a few have been commercially implemented. To date, only two bacteriocins have been approved for widespread use in the food industry: nisin, marketed as Nisaplin® with the active ingredient nisin A, and pediocin PA-1, sold under the brand name ALTA™2431. Therefore, most research in this area has focused on specific bacteriocins, such as nisin and some bacteriocins of class IIa [93,94].

6. Development of Bacteriocin Resistance

For a bacteriocin to be approved for general use, it must meet several key requirements. The first aspect is the efficiency of using bacteriocins. The bacteriocin must demonstrate a narrow spectrum of action and strong antimicrobial activity against target pathogens and, at the same time, should not affect technological microorganisms such as starter cultures or probiotics. The second aspect is safety. It must be non-toxic to humans and animals and not cause adverse effects [95,96]. The third and most important aspect is the potential risks of resistance development [97,98]. The development of highly tolerant or resistant strains is a significant concern, as it undermines the effectiveness of bacteriocins as biopreservatives [97]. The global problem of resistant foodborne pathogens is exacerbated by the international trade of raw and processed foods. This facilitates the spread of resistant strains across borders, making it a significant public health concern [72].
Numerous studies have explored the susceptibility of pathogenic bacteria, such as L. monocytogenes, to specific bacteriocins. However, comparing these studies can be challenging due to varying experimental methods and terminology. In the literature, bacteriocin resistance is often not clearly defined, and there is no consensus among researchers regarding what constitutes high, moderate, or low resistance levels [80]. A key element in susceptibility tests is the bacteriocin solution itself. Some studies use purified preparations, such as nisin, measured in milligrams or international units (IU), while others use fermentates from producer organisms, such as pediocin PA-1, measured in activity units (AU) [82]. In the study by Gravesen et al. [98], the resistance of L. monocytogenes to nisin was defined as a 10-fold increase in the minimum inhibitory concentration (MIC). If a pathogen could grow at concentrations higher than MIC, it was deemed resistant to the bacteriocin.
Microorganisms exhibit different types of resistance to antimicrobials: innate, apparent, or acquired. Innate resistance is genetically controlled and naturally associated with the organism. Differences in resistance among species and strains under identical conditions are typically due to innate factors. Mechanisms include cellular barriers (such as teichoic acids in Gram-positive bacteria), efflux mechanisms (pumping out compounds), lack of biochemical targets, and antimicrobial inactivation by enzymes. Natural resistance to nisin in L. monocytogenes occurs at frequencies ranging from less than 10−9 to less than 10−5 [99]. In contrast, resistance to class IIa bacteriocins has been observed in 1 to 8% of wild-type strains tested [72]. Apparent resistance relates to assay or application conditions. Susceptibility varies based on application settings and interacting stress conditions (such as high temperatures, low pH, or high pressure), which can affect resistance. Acquired resistance results from genetic changes via mutations or acquiring genetic material from plasmids, altering the microbial cell’s response to antimicrobials. Acquired resistance to bacteriocins in L. monocytogenes may be the result of factors resulting from human practices. Overuse of antimicrobial compounds in food preservation and other branches, such as agriculture, veterinary, cosmetics, and medicine, may create selection pressure on bacteria, encouraging the development of resistant strains. Furthermore, the use of sublethal concentrations of bacteriocins allows bacteria to survive and adapt, enhancing resistance [61]. Various genetic loci have been linked to these types of resistance [100,101]. Understanding these genes’ roles in bacteriocin resistance is crucial for optimizing bacteriocin use and continues to attract research interest [102]. The main mechanisms and genetic determinants associated with L. monocytogenes resistance to LAB bacteriocins are presented in Table 2.

6.1. Resistance via Changes in Receptor Expression

As previously noted, for many bacteriocins to be effective in eliminating bacteria, they need to bind to specific receptors on the target cell’s surface. These receptors act as docking sites, allowing the bacteriocin to attach and exert its lethal effects. Without the presence of these specific receptors, the bacteriocins cannot effectively interact with the bacterial cell, rendering them less effective or even ineffective. The phenomenon of resistance to nisin, a class I bacteriocin, was described by Gravesen et al. [81]. In this study, the researchers aimed to identify loci responsible for nisin resistance in L. monocytogenes. Their analysis revealed that the nisin-resistant mutant exhibited increased expression of a protein with strong homology to the glycosyltransferase domain of high-molecular-weight penicillin-binding proteins (PBPs). These membrane-bound proteins are crucial for cell wall biosynthesis through peptidoglycan chain extension and cross-linking. It was speculated that the increased expression and production of this protein might partially shield lipid II in the plasma membrane, thus reducing nisin’s efficacy by impeding its access to the binding site. The other authors observed a similar effect [81].
Resistance to subclass IIa bacteriocins in L. monocytogenes often involves changes in receptor expression. This resistance can arise through either the reduced expression or even loss of the Man-PTS system, a key element involved in sugar uptake. According to Vadyvaloo et al. [103], wild-type strains demonstrated faster growth in the presence of glucose, whereas the class IIa bacteriocin-resistant strains exhibited quicker growth in the absence of glucose. The variations in growth between the wild-type and resistant mutants on different carbohydrates suggest that the sugar metabolism pathways might be altered in the resistant strains. The man-PTS system is encoded by the mptACD operon. The level of mptACD expression has been shown to correlate with the level of bacteriocin sensitivity [61]. Survival of bacteria under stress conditions requires rapid changes in gene expression, which are controlled by the association of different alternative sigma factors. Previous studies reviewed by Bastos et al. [111] have identified four types of sigma factors in L. monocytogenes: σB (SigB), σH, RpoD, and RpoN.
The study by Robichon et al. [106] linked resistance to subclass IIa bacteriocins to the regulatory gene rpoN, which encodes the alternative sigma factor σ54. It was proposed that the transcription factor σ54 might regulate the expression of the Man-PTS receptor, as mutants of L. monocytogenes lacking rpoN [106] showed resistance to mesentericin Y105 (produced by Leuconostoc mesenteroides) and related subclass IIa bacteriocins. σ54 is known to be involved in the regulation of PTS expression. The study by Dalet et al. [112] discovered that the mannose family activator ManR and the PTS permease are essential for L. monocytogenes sensitivity to mesentericin Y105. σ54 activates the mptACD operon (mptA, mptC, and mptD genes), which codes for EIIAB, EIIC, and EIID in L. monocytogenes, alongside ManR, the transcriptional activator for σ54 [112]. Disruptions in the mptA or mptD genes led to resistance, and further in-frame deletions in the mptD gene were also linked to mesentericin Y105 resistance, suggesting that a specific domain of the MptD subunit is involved in target recognition by the bacteriocin. These findings were the first to suggest that EIIMan could serve as a receptor for subclass IIa bacteriocins [106]. Mutations in rpoN led to the loss of mptACD expression, resulting in resistance to mesentericin Y105 [112]. Similarly, mutations in ManR (encoded by manR) rendered the cells resistant to subclass IIa bacteriocins [108]. Both regulatory proteins, RpoN and ManR, are crucial for the active transcription of genes encoding the subclass IIa bacteriocin receptor.
In the works of Gravesen et al. [113] and Ramnath et al. [114], two different changes in PTS expression were correlated with the development of resistance to class IIa bacteriocins in L. monocytogenes. In the study by Ramnath et al. [109], a mutant of L. monocytogenes resistant to leucocin A (produced by Leuconostoc gelidum) was found to lack the IIAB subunit of the mannose PTS permease. Conversely, Gravesen et al. [113] identified that L. monocytogenes mutants resistant to pediocin PA-1 exhibited overexpression of the β-glucoside PTS permease. Gravesen et al. [108] examined eight mutants of L. monocytogenes and found that all high-level resistance strains showed increased expression of two putative β-glucoside-specific PTS genes. Additionally, these strains failed to synthesize the MptA subunit of the mannose-specific PTS, EIIMan. This suggests that spontaneous resistance to class IIa bacteriocins in L. monocytogenes arises through a single mechanism (downregulation of the Man-PTS gene) that causes two distinct changes in PTS expression. However, disruption of these genes in the resistant mutant did not confer sensitivity to pediocin. This indicates that increased expression of β-glucoside PTS permease is not a direct cause of resistance but is probably a regulatory consequence of acquired resistance through the abolition of mptACD expression [103]. Preventing mptACD expression directly confers resistance. Expression of mptACD could be prevented by mutations in all the factors mentioned earlier, e.g., rpoN, manR, or mptACD [112].
Since the IIC and IID subunits of the mptACD operon are likely membrane-bound, they were hypothesized to be potential targets for class IIa bacteriocins. When the mptACD operon of L. monocytogenes was expressed in an insensitive species like Lactococcus lactis, this strain became sensitive to various class IIa bacteriocins. Individual expression of each gene from the mptACD operon in Lactococcus lactis revealed that expressing mptC alone was enough to confer sensitivity. Therefore, the IIC subunit was proposed as the target molecule for class IIa bacteriocins [114].
Both Tessema et al. [102] and Kjos et al. [70] confirmed findings by Gravesen et al. [108] that the primary mechanism of resistance in L. monocytogenes involves the downregulation of Man-PTS gene expression. This downregulation, caused by the lack of a functional mptACD, reduces or eliminates receptor proteins, leading to high resistance levels. Furthermore, both studies identified additional resistance mechanisms. Tessema et al [99] found that resistant strains exhibited changes in carbon catabolite control, likely mediated by mptACD, along with cell envelope modifications and bacteriocin efflux through the TAT system, contributing to the resistance in sakacin P-resistant strains. Kjos et al. [70] noted that cells with intermediate resistance had high Man-PTS gene expression, similar to wild-type cells. This was linked to metabolic shifts and suggested changes in cell surface properties that affect bacteriocin-receptor interactions.

6.2. Resistance Due to Changes in the Cell Envelope

6.2.1. Resistance Due to Changes in the Cell Wall

Gram-positive bacteria, including the pathogenic L. monocytogenes, are characterized by the presence of peptidoglycan in their cell walls. This crucial component is a polymer made of sugars and amino acids, forming a protective layer outside the plasma membrane, which provides structural strength and rigidity. Peptidoglycan contains two types of anionic polymers: teichoic acids (TAs), which are covalently attached to the peptidoglycan, and lipoteichoic acids (LTAs), which consist of polyphosphoglycerol substituted with a D-alanyl (D-Ala) ester, anchored in the membrane by their glycolipid component [115]. Those components cause the cell wall to carry an anionic charge due to deprotonated phosphate groups [82]. Thus, altering the surface charge of the target cell wall emerges as a critical defense strategy against cationic bacteriocins. Changing the bacterial surface charge is likely to impact the initial electrostatic interaction between the peptide and the membrane, which is crucial for pore formation [72].
The dlt operon, consisting of four genes (dltA, dltB, dltC, and dltD), was characterized in the study by Abachin et al. [115]. These genes are responsible for incorporating D-alanine residues into cell-wall-associated LTAs. A mutant deficient in D-alanine, created by inactivating the dltA gene (which encodes a cytoplasmic D-alanine-D-alanyl carrier protein ligase), exhibited increased susceptibility to cationic peptides such as nisin. The study by Vadyvaloo et al. [103] also emphasized that decreasing the negative charge of the cell wall contributes to resistance. This reduction is achieved by increasing the D-alanine content in teichoic acids, which lowers the cell wall’s negative charge and, consequently, its susceptibility to bacteriocins. Gravesen et al. [108] demonstrated that a notable decrease in the expression of dltA, dal, and dat genes can reduce the availability of D-alanine. This shortage affects the incorporation of D-alanine into LTAs, TAs, and peptidoglycan.
Collins et al. [100] identified the lmo1967 locus in L. monocytogenes as key for innate nisin resistance. This locus is a homolog of the tellurite resistance gene telA. Mutant analysis revealed that mutants were four times more susceptible to nisin and twice as susceptible to certain antibiotics and tellurite. This study was the first to associate the telA gene with resistance to antimicrobials targeting the cell envelope.

6.2.2. Changes in the Fatty Acid Composition of the Cell Membrane

Research has consistently demonstrated that alterations in the surface charge of the cell wall significantly contribute to L. monocytogenes’ resistance to cationic bacteriocins. Additionally, it is hypothesized that this bacterium might adopt various cell membrane modifications to further bolster its resistance [116].
In the study by Vadyvaloo et al. [117], the researchers focused on the first mechanism involving cell membranes: the alteration of membrane fluidity. The study examined the relationship between leucocin A, a class IIa bacteriocin, and the composition of the major phospholipid, phosphatidylglycerol (PG), in both susceptible and resistant strains of L. monocytogenes. The analysis revealed that resistant strains had an increased ratio of unsaturated to saturated and short to long PG acyl chains. This shift towards PGs with shorter, unsaturated acyl chains increased membrane fluidity. This decrease may hinder the insertion of class IIa bacteriocins into the membrane and affect the stability of the pore complex, contributing to resistance. Membrane adaptation is likely just one of several mechanisms involved in resistance, and other mechanisms are necessary for complete resistance. Ming and Daeschel [118] also observed that a nisin-resistant mutant of L. monocytogenes had a higher proportion of straight-chain fatty acids compared to its parent strain, which exhibited a greater amount of branched-chain fatty acids. In addition, the resistant strain showed less phosphatidylglycerol and cardiolipin than the wild-type [118]. In L. monocytogenes ATCC 700302, which is resistant to nisin, researchers observed comparable alterations in membrane fatty acid composition, including an increase in long-chain fatty acids, a decrease in short-chain fatty acids, and a reduction in the C15/C17 ratio [111]. The observed changes in fatty acid composition suggest a decrease in cytoplasmic membrane fluidity. This increased stiffness likely impedes nisin from penetrating the membrane.
Vadyvaloo et al. [103] explored another mechanism behind bacteriocin resistance in L. monocytogenes: the alteration of membrane surface charge. The cationic nature of peptides allows them to interact with negatively charged cell surfaces, leading to membrane permeabilization [72,82]. Altering the bacterial surface charge can thus impact the electrostatic interaction between the peptide and membrane [108]. One method of charge modulation is through L-lysinylation of TA and LTAs in the cell wall. Vadyvaloo et al. [103] found that highly resistant strains showed increased lysinylation of membrane phospholipids. Normally, phospholipids such as L-lysyl-PG and L-lysyl-cardiolipin are negatively charged, but adding L-lysine to produce lysylphosphatidylglycerol, a basic phospholipid [118], changes their net charge to positive, reducing the anionic properties of cell permeability barriers and thus decreasing susceptibility to cationic antimicrobial compounds.
Verheul et al. [104] demonstrated that modifications in the cytoplasmic membrane composition could contribute to lantibiotic resistance in L. monocytogenes. In their study, a nisin-resistant mutant of L. monocytogenes Scott A, developed through exposure to increasing concentrations of nisin, showed reduced diphosphatidylglycerol and increased phosphatidylglycerol production compared to the parent strain. Nisin penetrates diphosphatidylglycerol lipid monolayers more effectively than other lipids, including phosphatidylglycerol; thus, the resistance in the mutant strain was linked to the decreased diphosphatidylglycerol content in its cytoplasmic membrane. Additionally, factors such as the zwitterionic phosphatidylethanolamine content in the phospholipids of L. monocytogenes can influence the net surface charge [119].
The lysinylation process requires the MprF protein, a membrane-localized lysylphosphatidylglycerol synthetase encoded by the mprF gene [77]. When there is a mutation in the mprF gene, it interferes with the incorporation of lysine into membrane phospholipids. This results in an increased negative charge of the cell envelope, making the bacteria more vulnerable to bacteriocins and other cationic antimicrobial peptides (CAMPs) [120].
The study by Mandin et al. [109] underscored the importance of VirR, a response regulator in the two-component signal transduction system (2CS) VirRS, in L. monocytogenes. VirRS system proteins are encoded by vir operon that includes a response regulator gene (virR) and a histidine kinase gene (virS). VirR, as revealed through transcriptomic approaches, positively regulates the transcription of 12 genes, including mprF and dltACD operon, both involved in defense against bacteriocin. It has been demonstrated that inactivating VirR increases bacterial susceptibility to bacteriocins [120]. Additionally, the VirRS system in L. monocytogenes is influenced by alternative sigma factors, SigB, which contributes to resistance to bacteriocins.
Several other 2CSs play a role in bacteriocin resistance. One notable example is the AnrAB, an ATP-binding cassette (ABC) transporter in L. monocytogenes, which not only contributes to innate bacteriocin resistance but also provides protection against bacitracin and beta-lactam antibiotics [121]. After dltA and mprF, anrB is identified as the third VirRS-regulated locus in L. monocytogenes linked to nisin resistance [109]. Additionally, expression studies have shown that AnrAB is regulated by RpoN [122]. It is hypothesized that AnrAB, VirRS, and Lmo1746-Lmo1747 form an antimicrobial sensing and detoxification system similar to the VraDE-BraSR-BraDE circuit in Staphylococcus aureus [110]. The genes lmo1746-lmo1747, also known as virAB, encode a putative ABC transporter crucial for VirR activity. The expression of virAB is essential for nisin resistance [122]. Cotter et al. [123] and Bergholz et al. [110] described another significant example, the LisRK two-component system. This system in L. monocytogenes not only helps the bacterium respond to acidic and oxidative stress but also plays a crucial role in nisin resistance and the pathogen’s inherent resistance to cephalosporin antibiotics.

6.3. Role of Cations in Resistance Against Bacteriocins

The studies by Abee et al. [124] and Crandall and Montville [119] highlight the significance of divalent cations in stabilizing the cytoplasmic membrane of nisin-resistant cells. This stabilization could involve interactions between the cations and envelope components such as negatively charged teichoic acids; however, it can also involve interfering with nisin’s binding. Abee et al. [124] found that divalent cations (Mg2+ and Ca2+) decreased the rate of potassium (K+) efflux from whole cells of L. monocytogenes. Scott A. Crandall and Montville [119] suggested that divalent and trivalent cations might inhibit the electrostatic interactions between the positively charged nisin molecules and the negatively charged phospholipid headgroups. Similar results were obtained by Kaur et al. [125]. Kaur et al. [125] found that adding divalent cations (Mg2+, Ca2+, and Mn2+) significantly decreased the inhibitory effects of nisin, pediocin 34, and enterocin FH99 against L. monocytogenes. However, when EDTA was added, the inhibitory activity was restored, indicating that divalent cations likely interfere with the initial electrostatic interaction between the positively charged bacteriocin and the negatively charged membrane phospholipids.
The study by Kaur et al. [125] also observed that resistant L. monocytogenes cells tended to form aggregates. This aggregation may lead to biofilm formation, serving as an additional resistance mechanism by reducing the contact surface area with bacteriocins, making it more difficult for the antimicrobial compounds to exert their effects. Biofilm formation is one of the resistance strategies of L. monocytogenes against bacteriocins. In response to nisin exposure, L. monocytogenes transitions from a planktonic (free-floating) state to a sessile organization, forming biofilms to better withstand environmental stress. Sublethal concentrations of nisin trigger the upregulation of proteins linked to biofilm formation in this species [126]. Liu et al. [127] discovered that the cell surface of pediocin-resistant L. monocytogenes variants exhibited increased hydrophobicity, potentially leading to greater cell aggregate formation. Likewise, Martínez and Rodríguez [128] found that nisin-resistant L. monocytogenes Lm41 mutant displayed higher hydrophobicity compared to its wild-type strain.

6.4. Cross Resistance Related to Growth Conditions

Elements such as bacterial growth phase, temperature, pH, and nutrient availability can influence resistance gene expression and overall bacterial resistance. L. monocytogenes demonstrates remarkable adaptability to the tough conditions in food processing environments, highlighting the importance of studying how stress conditions collectively enhance its resistance to bacteriocins. The study by Begley et al. [129] demonstrated a link between nisin resistance and the ability of bacteria to adapt to acidic environments, highlighting the crucial role of the glutamate decarboxylase (GAD) system. This system converts glutamate to γ-aminobutyrate (GABA) and carbon dioxide, facilitated by the enzymes GadD1, GadD2, and GadD3. This conversion also generates ATP, boosting the bacterial cell’s energy reserves. In the next stage, GABA is exported from the cell by the proteins GadT1 and GadT2. Research indicated that bacteria lacking the GadD1 gene struggled to survive in the presence of nisin, showing a 40% reduction in ATP levels; thus, GadD1 is proposed to play a key role in maintaining ATP levels, countering nisin’s harmful effects, and supporting bacterial survival [129]. Jydegaard et al. [130] investigated the impact of the growth phase, osmotic shock, and low-temperature shock on the resistance of L. monocytogenes to the bacteriocins nisin and pediocin PA-1. They found that the growth phase significantly impacted resistance, with stationary phase bacteria showing higher resistance to both bacteriocins compared to those in the exponential phase. Additionally, cultures exposed to osmotic stress (6.5% NaCl) and cold stress (5 °C for 60–80 min) exhibited increased tolerance. Research has sought to clarify this phenomenon. It is likely attributed to changes in the electrostatic interactions between bacteriocins and the cell surface when ion concentrations are higher [130]. Additionally, increased osmolarity in the culture medium can alter cell morphology, leading to modifications in the cell envelope [130].
De Martinis et al. [99] investigated the influence of salt, pH, and temperature on the effectiveness of nisin against L. monocytogenes. The research found that at temperatures 20 °C and 30 °C, resistance to nisin was stable regardless of pH and salt concentration. At 10 °C, nisin resistance decreased with lower pH and salt concentrations. Interestingly, low salt levels (2–3.5%) seemed to protect L. monocytogenes at 10 °C, confirming earlier findings by Cole et al. [130] about optimal salt concentrations for bacterial growth at low temperatures. This suggests that salt can help more nisin-resistant colonies survive in cold environments. Furthermore, the study showed that nisin resistance remained stable after repeated exposure, highlighting that relying solely on nisin as a preservative could lead to the development of stable resistant mutants. Therefore, nisin should be used as part of a multi-hurdle approach to food preservation [131]. These reports were confirmed in the study by Bergholz et al. [110]. This study examined cross-resistance in L. monocytogenes to nisin under salt stress and low-temperature conditions. They found that exposure to salt stress at low temperatures significantly increased the pathogen’s resistance to nisin. This stress increased the expression of genes related to nisin resistance, including the response regulator LiaRS. By constructing liaR deletion mutations in seven strains and exposing them to 6% NaCl, they found that wild-type strains exhibited a marked increase in nisin resistance after salt exposure [113]. Conversely, liaR mutants were more sensitive, showing that LiaFSR induction provides cross-protection against nisin. Additionally, LiaR-regulated genes such as lmo1746 and telA contributed to this resistance. These findings suggest that environmental stresses similar to those found in foods can influence L. monocytogenes’ resistance to antimicrobials such as nisin, emphasizing the need to consider potential cross-protective effects when applying control measures against this pathogen [110].

6.5. Cross-Resistance to Multiple Bacteriocins

Using a combination of multiple bacteriocins simultaneously can help mitigate the risk of resistance in L. monocytogenes. Therefore, it is crucial to study the potential for cross-resistance between different bacteriocins [74,82]. The findings on cross-resistance in L. monocytogenes present varied outcomes [131] reported no cross-resistance between nisin (Lactococcus lactis), pediocin PA-1 (Pediococcus acidilactici) and bavaricin A (Lactobacillus bavaricus), whereas Crandall and Montville [119] reported that nisin resistance in L. monocytogenes conferred cross-resistance to pediocin PA-1. Similarly, Gravesen et al. [132] identified cross-resistance between nisin and subclass IIa bacteriocins such as pediocin PA-1 and leucocin A. Another study by Crandall and Montville [119] showed that a strain of L. monocytogenes exhibited cross-resistance to nisin, pediocin PA-1, and leuconocin S. Cross-resistance has been observed not only between different classes of bacteriocins but also within the same class. Crandall and Montville [119] also observed complete cross-resistance among subclass IIa bacteriocins such as pediocin PA-1, leucocin A, and carnobacteriocin B2.

7. Strategies to Overcome Bacteriocin Resistance

It is vital to grasp both the causes and mechanisms behind resistance development for effective bacteriocin management. Strategies are essential to minimize resistance risk while ensuring balanced bacteriocin use to maintain effectiveness. Simultaneously, monitoring bacterial populations for resistance is crucial for early detection and prompt responses [111,133]. First, inappropriate use should be limited. Bacteriocins need to be used precisely and in a controlled manner to avoid overuse, thereby reducing the pressure on bacteria to develop resistance [97]. Second, optimizing doses and schedules is crucial to maximize efficacy while minimizing the risk of selecting resistant strains. Additionally, rotating or cyclic use of different bacteriocins can reduce selection pressure, making it harder for bacteria to develop resistance [133].
In food technology, combining bacteriocins with other preservatives also can be an effective strategy [134]. By employing multiple bacteriocins with different mechanisms of action at the same time, the approach reduces the risk of resistance. Bacteria would need to develop resistance to several bacteriocins simultaneously, making it significantly more challenging for them to survive. For instance, combining nisin and pediocin PA-1 significantly lowered the occurrence of resistance development in L. monocytogenes [108]. Moreover, the combined use of bacteriocins significantly reduced MIC, effectively lowering the required inhibitory dosage [77]. Additionally, a multiple-hurdle preservation strategy, combining bacteriocins with other methods, can reduce selection pressure on bacteria [130]. Kaur et al. [125] discovered that L. monocytogenes mutants resistant to nisin, pediocin 34, and enterocin FH99 did not gain resistance to low pH, sodium chloride, or sodium nitrite; instead, these mutants were as sensitive or even more sensitive than the wild-type strain. Bergholz et al. [110] indicated that salt stress at low temperatures may offer cross-protection to L. monocytogenes against nisin. Therefore, it is important to consider the potential for cross-protective effects when utilizing various hurdle technologies for food preservation.
Other approaches involve developing new bacteriocins with unique mechanisms [111,133]. This includes creating genetically engineered bacteriocins with improved stability, greater efficacy, and a lower likelihood of inducing resistance [77]. For example, nisin A has been modified to nisin V through a single amino acid substitution, resulting in increased efficacy against L. monocytogenes compared to nisin A [135]. Considering all approaches, bioengineering remains one of the most promising methods for enhancing the antimicrobial activity of bacteriocins [136].
Monitoring and surveillance of resistance are critical. Regular checks on bacterial populations for resistance to bacteriocins allow for early detection and rapid response. Understanding the mechanisms and genetic determinants of resistance is vital for effective monitoring. To sum up, a holistic approach is necessary to minimize bacterial resistance to bacteriocins. Collaboration between scientists, the food industry, and healthcare is essential for managing and maintaining the effectiveness of bacteriocins in combating pathogenic bacteria [133].

8. Conclusions

L. monocytogenes is a formidable foodborne pathogen due to its ability to adapt to harsh food processing conditions and its persistence in food products. Bacteriocins, particularly those produced by LAB, show promise as biocontrol agents to enhance food safety by eliminating L. monocytogenes [137]. However, increasing resistance to these bacteriocins poses a significant challenge. Research on resistance mechanisms has primarily been conducted in laboratory settings [92]. Since bacteriocins are mainly used for biopreserving food, further studies in food model systems are crucial to understanding resistance frequency and its impact on food microflora. The composition of food systems can affect bacteriocin activity and resistance development [82]. Exploring the genetic determinants of resistance mechanisms can help develop strategies to enhance bacterial susceptibility and design new bacteriocins that circumvent resistance [138]. Since resistance can spread to other bacteriocins, particularly within the same subclass, it is vital to avoid widespread use across multiple industries and limit usage to where they are most effective [139]. Like antibiotic resistance, bacteriocin resistance can be equally detrimental, so careful consideration is necessary when using bacteriocins in daily applications.

Author Contributions

Conceptualization, A.O.-S. and A.Z.; formal analysis, A.O.-S.; data curation, A.Z.; writing—original draft preparation, A.Z.; writing—review and editing, A.Z. and A.O.-S.; supervision, A.O.-S.; project administration, A.O.-S.; funding acquisition, A.O.-S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

No new data were created or analyzed in this study.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Dincer, E. Detection of Listeria species by conventional culture-dependent and alternative rapid detection methods in retail ready-to-eat foods in Turkey. J. Microbiol. Biotechnol. 2024, 34, 349–357. [Google Scholar] [CrossRef]
  2. Jadhav, S.; Bhave, M.; Palombo, E.A. Methods used for the detection and subtyping of Listeria monocytogenes. J. Microbiol. Methods 2018, 88, 327–341. [Google Scholar] [CrossRef] [PubMed]
  3. Gouin, E.; Mengaud, J.; Cossart, P. The virulence gene cluster of Listeria monocytogenes is also present in Listeria ivanovii, an animal pathogen, and Listeria seeligeri, a nonpathogenic species. Infect. Immun. 1997, 62, 3550–3553. [Google Scholar] [CrossRef]
  4. Orsi, R.H.; Liao, J.; Carlin, C.R.; Wiedmann, M. Taxonomy, ecology, and relevance to food safety of the genus Listeria with a particular consideration of new Listeria species described between 2010 and 2022. mBio 2024, 15, 0093823. [Google Scholar] [CrossRef] [PubMed]
  5. Palaiodimou, L.; Fanning, S.; Fox, E.M. Genomic insights into persistence of Listeria species in the food processing environment. J. Appl. Microbiol. 2021, 131, 2082–2094. [Google Scholar] [CrossRef] [PubMed]
  6. Mafuna, T.; Matle, I.; Magwedere, K.; Pierneef, R.E.; Reva, O.N. Comparative genomics of Listeria species recovered from meat and food processing facilities. Microbiol. Spectr. 2022, 10, e01189-22. [Google Scholar] [CrossRef]
  7. Bahrami, A.; Delshadi, R.; Assadpour, E.; Jafari, S.M.; Williams, L. Antimicrobial-loaded nanocarriers for food packaging applications. Adv. Colloid Interface Sci. 2020, 278, 102140. [Google Scholar] [CrossRef]
  8. Matle, I.; Mbatha, K.R.; Madoroba, E. A review of Listeria monocytogenes from meat and meat products: Epidemiology, virulence factors, antimicrobial resistance, and diagnosis. Onderstepoort J. Vet. Res. 2020, 87, 1869. [Google Scholar] [CrossRef]
  9. Gandhi, M.; Chikindas, M.L. Listeria: A foodborne pathogen that knows how to survive. Int. J. Food Microbiol. 2007, 113, 1–15. [Google Scholar] [CrossRef]
  10. El-Hajjaji, S.; Gérard, A.; De Laubier, J.; Di Tanna, S.; Lainé, A.; Patz, V.; Sindic, M. Assessment of growth and survival of Listeria monocytogenes in raw milk butter by durability tests. Int. J. Food Microbiol. 2020, 321, 108541. [Google Scholar] [CrossRef] [PubMed]
  11. Nyarko, E.B.; Donnelly, C.W. Listeria monocytogenes: Strain heterogeneity, methods, and challenges of subtyping. J. Food Sci. 2015, 80, M2868–M2878. [Google Scholar] [CrossRef] [PubMed]
  12. Alessandria, V.; Rantsiou, K.; Dolci, P.; Cocolin, L. Molecular methods to assess Listeria monocytogenes route of contamination in a dairy processing plant. Int. J. Food Microbiol. 2010, 141, S156–S162. [Google Scholar] [CrossRef]
  13. Ferreira, V.; Wiedmann, M.; Teixeira, P.; Stasiewicz, M.J. Listeria monocytogenes Persistence in Food-Associated Environments: Epidemiology, Strain Characteristics, and Implications for Public Health. J. Food Prot. 2014, 77, 150–170. [Google Scholar] [CrossRef]
  14. Peccio, A.; Autio, T.; Korkeala, H.; Rosmini, R.; Trevisani, M. Listeria monocytogenes occurrence and characterization in meat-producing plants. Lett. Appl. Microbiol. 2003, 37, 234–238. [Google Scholar] [CrossRef] [PubMed]
  15. Churchill, K.J.; Sargeant, J.M.; Farber, J.M.; O’Connor, A.M. Prevalence of Listeria monocytogenes in select ready-to-eat foods: Deli meat, soft cheese, and packaged salad: A systematic review and meta-analysis. J. Food Prot. 2019, 82, 344–357. [Google Scholar] [CrossRef] [PubMed]
  16. Bagheri Darvish, H.; Bahrami, A.; Jafari, S.M.; Williams, L. Micro/nanoencapsulation strategy to improve the efficiency of natural antimicrobials against Listeria monocytogenes in food products. Crit. Rev. Food Sci. Nutr. 2021, 61, 1241–1259. [Google Scholar] [CrossRef]
  17. Cheng, Y.; Wang, X.; Liu, Y.; Qin, X.; Li, Z. Growth and survival characteristics of Listeria monocytogenes of different sources and subtypes. LWT 2023, 184, 115114. [Google Scholar] [CrossRef]
  18. Radoshevich, L.; Cossart, P. Listeria monocytogenes: Towards a complete picture of its physiology and pathogenesis. Nat. Rev. Microbiol. 2018, 16, 32–46. [Google Scholar] [CrossRef]
  19. Li, C.; Zeng, H.; Zhang, J.; He, W.; Ling, N.; Chen, M.; Wu, S.; Lei, T.; Wu, H.; Ye, Y.; et al. Prevalence, antibiotic susceptibility, and molecular characterization of Cronobacter spp. isolated from edible mushrooms in China. Front. Microbiol. 2019, 10, 283. [Google Scholar] [CrossRef]
  20. Lopes-Luz, L.; Mendonça, M.; Fogaça, M.B.T.; Saavedra, D.P.; Bentivoglio-Silva, B.G.; Conceição, F.R.; Stefani MM de, A.; Kipnis, A.; Bührer-Sékula, S. Detection of Listeria monocytogenes using an immunochromatographic point of care test based on anti-internalin A and B antibodies and a nano-biotinylated detection complex. LWT 2023, 188, 115336. [Google Scholar] [CrossRef]
  21. Bierne, H.; Hamon, M. Targeting host epigenetic machinery: The Listeria paradigm. Cell Microbiol. 2020, 22, e13169. [Google Scholar] [CrossRef] [PubMed]
  22. Poimenidou, S.V.; Dalmasso, M.; Papadimitriou, K.; Fox, E.M.; Skandamis, P.; Jordan, K. Virulence gene sequencing highlights similarities and differences in sequences in Listeria monocytogenes serotype 1/2a and 4b strains of clinical and food origin from 3 different geographic locations. Front. Microbiol. 2018, 9, 1103. [Google Scholar] [CrossRef] [PubMed]
  23. Buchanan, R.L.; Gorris, L.G.M.; Hayman, M.M.; Jackson, T.C.; Whiting, R.C. A review of Listeria monocytogenes: An update on outbreaks, virulence, dose-response, ecology, and risk assessments. Food Control 2018, 75, 1–13. [Google Scholar] [CrossRef]
  24. Cossart, P.; Lebreton, A. A trip in the “New Microbiology” with the bacterial pathogen Listeria monocytogenes. FEBS Lett. 2014, 588, 2437–2445. [Google Scholar] [CrossRef] [PubMed]
  25. Roldgaard, B.B.; Andersen, J.B.; Hansen, T.B.; Christensen, B.B.; Licht, T.R. Comparison of three Listeria monocytogenes strains in a guinea-pig model simulating food-borne exposure. FEMS Microbiol. Lett. 2009, 291, 88–94. [Google Scholar] [CrossRef]
  26. Scallan, E.; Hoekstra, R.M.; Angulo, F.J.; Tauxe, R.V.; Widdowson, M.A.; Roy, S.L.; Jones, J.L.; Griffin, P.M. Foodborne illness acquired in the United States—Major pathogens. Emerg. Infect. Dis. 2021, 17, 7–15. [Google Scholar] [CrossRef]
  27. Heidarlo, M.N.; Lotfollahi, L.; Yousefi, S.; Lohrasbi, V.; Irajian, G.; Talebi, M. Analysis of virulence genes and molecular typing of Listeria monocytogenes isolates from human, food, and livestock from 2008 to 2016 in Iran. Trop. Anim. Health Prod. 2021, 53, 127. [Google Scholar] [CrossRef] [PubMed]
  28. Swaminathan, B.; Gerner-Smidt, P. The epidemiology of human listeriosis. Microbes Infect. 2007, 9, 1236–1243. [Google Scholar] [CrossRef]
  29. Khan, J.A.; Rathore, R.S.; Khan, S.; Ahmad, I. In vitro detection of pathogenic Listeria monocytogenes from food sources by conventional, molecular and cell culture method. Braz. J. Microbiol. 2014, 44, 751–758. [Google Scholar] [CrossRef] [PubMed]
  30. Zhu, Q.; Gooneratne, R.; Hussain, M.A. Listeria monocytogenes in fresh produce outbreaks, prevalence, and contamination levels. Foods 2017, 6, 21. [Google Scholar] [CrossRef] [PubMed]
  31. Dong, Z.; Sun, Y.; Cao, Q.; Liu, H.; Liu, Y.; Cao, Q.; Wei, H.; Song, C.; Gou, H.; Xue, H. Prevalence and biological characteristics of Listeria species isolated from livestock and poultry meat in Gansu Province, China. Pol. J. Microbiol. 2023, 72, 11–20. [Google Scholar] [CrossRef]
  32. Shamloo, E.; Hosseini, H.; Abdi Moghadam, Z.; Halberg Larsen, M.; Haslberger, A.; Alebouyeh, M. Importance of Listeria monocytogenes in Food Safety: A Review of Its Prevalence, Detection, and Antibiotic Resistance. Iran J. Vet. Res. 2019, 20, 241–254. [Google Scholar]
  33. Gahan, C.G.; Hill, C. Listeria monocytogenes: Survival and adaptation in the gastrointestinal tract. Front. Cell. Infect. Microbiol. 2014, 4, 9. [Google Scholar] [CrossRef] [PubMed]
  34. Freitag, N.E.; Port, G.C.; Miner, M.D. Listeria monocytogenes—From saprophyte to intracellular pathogen. Nat. Rev. Microbiol. 2009, 7, 623–628. [Google Scholar] [CrossRef] [PubMed]
  35. Kathariou, S. Listeria monocytogenes Virulence and Pathogenicity: A Food Safety Perspective. J. Food Prot. 2002, 65, 1811–1829. [Google Scholar] [CrossRef]
  36. Chen, J.; Luo, X.; Jiang, L.; Jin, P.; Wei, W.; Liu, D.; Fang, W. Molecular characteristics and virulence potential of Listeria monocytogenes isolates from Chinese food systems. Food Microbiol. 2009, 26, 103–111. [Google Scholar] [CrossRef] [PubMed]
  37. Briers, Y.; Klumpp, J.; Schuppler, M.; Loessner, M.J. Genome sequence of Listeria monocytogenes Scott A, a clinical isolate from a food-borne listeriosis outbreak. J. Bacteriol. 2011, 193, 4284–4285. [Google Scholar] [CrossRef]
  38. Barre, L.; Angelidis, A.S.; Boussaid, D.; Brasseur, E.D.; Manso, E.; Gnanou Besse, N. Applicability of the EN ISO 11290-1 standard method for Listeria monocytogenes detection in presence of new Listeria species. Int. J. Food Microbiol. 2016, 238, 281–287. [Google Scholar] [CrossRef]
  39. Garedew, L.; Taddese, A.; Biru, T.; Nigatu, S.; Kebede, E.; Ejo, M.; Fikru, A.; Birhanu, T. Prevalence and antimicrobial susceptibility profile of Listeria species from ready-to-eat foods of animal origin in Gondar Town, Ethiopia. BMC Microbiol. 2015, 15, 100. [Google Scholar] [CrossRef]
  40. Wang, Y.; Zhao, A.; Zhu, R.; Lan, R.; Jin, D.; Cui, Z.; Wang, Y.; Li, Z.; Wang, Y.; Xu, J.; et al. Genetic diversity and molecular typing of Listeria monocytogenes in China. BMC Microbiol. 2012, 12, 119. [Google Scholar] [CrossRef] [PubMed]
  41. European Commission. Commission Regulation (EC) No 2073/2005 of 15 November 2005 on microbiological criteria for foodstuffs. Off. J. Eur. Union 2005, L338, 1–26. [Google Scholar]
  42. Lomonaco, S.; Nucera, D.; Filipello, V. The evolution and epidemiology of Listeria monocytogenes in Europe and the United States. Infect. Genet. Evol. 2015, 35, 172–183. [Google Scholar] [CrossRef] [PubMed]
  43. EN ISO 11290-1:2017; Microbiology of the Food Chain—Horizontal Method for the Detection and Enumeration of Listeria monocytogenes and Listeria spp.—Part 1: Detection Method. European Committee for Standardization (CEN): Brussels, Belgium, 2017.
  44. EN ISO 11290-2:2017; Microbiology of the Food Chain—Horizontal Method for the Detection and Enumeration of Listeria monocytogenes and Listeria spp.—Part 2: Enumeration Method. European Committee for Standardization (CEN): Brussels, Belgium, 2017.
  45. Doumith, M.; Buchrieser, C.; Glaser, P.; Jacquet, C.; Martin, P. Differentiation of the major Listeria monocytogenes serovars by multiplex PCR. J. Clin. Microbiol. 2004, 42, 3819–3822. [Google Scholar] [CrossRef] [PubMed]
  46. Szymczak, B.; Szymczak, M.; Trafiałek, J. Prevalence of Listeria species and Listeria monocytogenes in ready-to-eat foods in the West Pomeranian region of Poland: Correlations between the contamination level, serogroups, ingredients, and producers. Food Microbiol. 2020, 91, 103532. [Google Scholar] [CrossRef]
  47. Kawacka, I.; Olejnik-Schmidt, A. Genoserotyping of Listeria monocytogenes strains originating from meat products and meat processing environments. Zywnosc Nauka Technol. Jakosc/Food Sci. Technol. Qual. 2022, 29, 34–44. [Google Scholar] [CrossRef]
  48. Kazmierczak, M.J.; Mithoe, S.C.; Boor, K.J.; Wiedmann, M. Listeria monocytogenes σB regulates stress response and virulence functions. J. Bacteriol. 2023, 185, 5722–5734. [Google Scholar] [CrossRef]
  49. Bucur, F.I.; Grigore-Gurgu, L.; Crauwels, P.; Riedel, C.U.; Nicolau, A.I. Resistance of Listeria monocytogenes to stress conditions encountered in food and food processing environments. Front. Microbiol. 2018, 9, 2700. [Google Scholar] [CrossRef] [PubMed]
  50. Arioli, S.; Montanari, C.; Magnani, M.; Tabanelli, G.; Patrignani, F.; Lanciotti, R.; Mora, D.; Gardini, F. Modelling of Listeria monocytogenes Scott A after a mild heat treatment in the presence of thymol and carvacrol: Effects on culturability and viability. J. Food Eng. 2019, 240, 73–82. [Google Scholar] [CrossRef]
  51. Shen, Q.; Jangam, P.M.; Soni, K.A.; Nannapaneni, R.; Schilling, W.; Silva, J.L. Low, medium, and high heat-tolerant strains of Listeria monocytogenes and increased heat stress resistance after exposure to sublethal heat. J. Food Prot. 2014, 77, 1298–1307. [Google Scholar] [CrossRef]
  52. Wiktorczyk-Kapischke, N.; Skowron, K.; Grudlewska-Buda, K.; Wałecka-Zacharska, E.; Korkus, J.; Gospodarek-Komkowska, E. Adaptive response of Listeria monocytogenes to the stress factors in the food processing environment. Front. Microbiol. 2021, 12, 710085. [Google Scholar] [CrossRef]
  53. Osek, J.; Lachtara, B.; Wieczorek, K. Listeria monocytogenes—How this pathogen survives in food-production environments. Front. Microbiol. 2022, 13, 866462. [Google Scholar] [CrossRef] [PubMed]
  54. Chan, Y.C.; Raengpradub, S.; Boor, K.J.; Wiedmann, M. Microarray-based characterization of the Listeria monocytogenes cold regulon in log- and stationary-phase cells. Appl. Environ. Microbiol. 2007, 73, 6484–6498. [Google Scholar] [CrossRef] [PubMed]
  55. Cordero, N.; Maza, F.; Navea-Perez, H.; Aravena, A.; Marquez-Fontt, B.; Navarrete, P.; Figueroa, G.; González, M.; Latorre, M.; Reyes-Jara, A. Different transcriptional responses from slow and fast growth rate strains of Listeria monocytogenes adapted to low temperature. Front. Microbiol. 2016, 7, 229. [Google Scholar] [CrossRef] [PubMed]
  56. O’Byrne, C.P.; Karatzas, K.A. The role of Sigma B (σB) in the stress adaptations of Listeria monocytogenes: Overlaps between stress adaptation and virulence. Adv. Appl. Microbiol. 2008, 65, 115–140. [Google Scholar]
  57. Schmid, B.; Klumpp, J.; Raimann, E.; Loessner, M.J.; Stephan, R.; Tasara, T. Role of cold shock proteins in growth of Listeria monocytogenes under cold and osmotic stress conditions. Appl. Environ. Microbiol. 2009, 75, 1621–1627. [Google Scholar] [CrossRef]
  58. Hill, D.; Sugrue, I.; Arendt, E.; Hill, C.; Stanton, C. Recent advances in microbial fermentation for dairy and health. F1000Research 2017, 6, 751. [Google Scholar] [CrossRef] [PubMed]
  59. Cotter, P.D.; Hill, C.; Ross, R.P. Bacteriocins: Developing innate immunity for food. Nat. Rev. Microbiol. 2005, 3, 777–788. [Google Scholar] [CrossRef] [PubMed]
  60. Lund, P.; Tramonti, A.; De Biase, D. Coping with low pH: Molecular strategies in neutralophilic bacteria. FEMS Microbiol. Rev. 2014, 38, 1091–1125. [Google Scholar] [CrossRef]
  61. Kaur, G.; Malik, R.K.; Mishra, S.K.; Singh, T.P.; Bhardwaj, A.; Singroha, G.; Vij, S.; Kumar, N. Nisin and class IIa bacteriocin resistance among Listeria and other foodborne pathogens and spoilage bacteria. Microb. Drug Resist. 2011, 17, 197–205. [Google Scholar] [CrossRef] [PubMed]
  62. Lopetuso, L.R.; Giorgio, M.E.; Saviano, A.; Scaldaferri, F.; Gasbarrini, A.; Cammarota, G. Bacteriocins and bacteriophages: Therapeutic weapons for gastrointestinal diseases? Int. J. Mol. Sci. 2019, 20, 183. [Google Scholar] [CrossRef]
  63. Parada, J.L.; Caron, C.R.; Medeiros, A.B.P.; Soccol, C.R. Bacteriocins from lactic acid bacteria: Purification, properties and use as biopreservatives. Braz. Arch. Biol. Technol. 2007, 50, 521–542. [Google Scholar] [CrossRef]
  64. Ansari, A. Bacteriocin from LAB for medical and health applications. In Beneficial Microorganisms in Medical and Health Applications; Liong, M.T., Ed.; Springer: Cham, Switzerland, 2015; pp. 199–221. [Google Scholar]
  65. De Vuyst, L.; Leroy, F. Bacteriocins from lactic acid bacteria: Production, purification, and food applications. J. Mol. Microbiol. Biotechnol. 2007, 13, 194–209. [Google Scholar] [CrossRef]
  66. Alvarez-Sieiro, P.; Montalbán-López, M.; Mu, D.; Kuipers, O.P. Bacteriocins of lactic acid bacteria: Extending the family. Appl. Microbiol. Biotechnol. 2016, 100, 2939–2951. [Google Scholar] [CrossRef] [PubMed]
  67. De Lira, F.M.; Tanaka, F.Y.R.; Rios, E.A.; Carrilho, S.M.; de Abreu, S.S.; Ferreira, G.F.; Gonzaga, N.; Pereira, U.P.; Tamanini, R.; Fagnani, R.; et al. Identification of lactic acid bacteria with anti-listeria activity. Characterization and application of a bacteriocinogenic strain in the control of Listeria monocytogenes in cheese. J. Dairy Res. 2023, 90, 318–323. [Google Scholar] [CrossRef] [PubMed]
  68. Juturu, V.; Wu, J.C. Microbial production of bacteriocins: Latest research development and applications. Biotechnol. Adv. 2018, 36, 2187–2200. [Google Scholar] [CrossRef] [PubMed]
  69. Klaenhammer, T.R. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. Rev. 1993, 12, 39–85. [Google Scholar] [CrossRef]
  70. Kjos, M.; Borrero, J.; Opsata, M.; Birri, D.J.; Holo, H.; Cintas, L.M.; Snipen, L.; Hernández, P.E.; Nes, I.F.; Diep, D.B. Target recognition, resistance, immunity and genome mining of class II bacteriocins from Gram-positive bacteria. Microbiology 2011, 157, 3256–3267. [Google Scholar] [CrossRef] [PubMed]
  71. Cui, Y.; Zhang, C.; Wang, Y.; Shi, J.; Zhang, L.; Ding, Z.; Qu, X.; Cui, H. Class IIa bacteriocins: Diversity and new developments. Int. J. Mol. Sci. 2012, 13, 16668–16707. [Google Scholar] [CrossRef]
  72. Ennahar, S.; Sonomoto, K.; Ishizaki, A. Class IIa bacteriocins from lactic acid bacteria: Antibacterial activity and food preservation. J. Biosci. Bioeng. 1999, 87, 705–716. [Google Scholar] [CrossRef]
  73. Gänzle, M.G.; Vogel, R.F. Bacteriocins from lactic acid bacteria: Mode of action and potentials in food preservation and control of foodborne pathogens. Appl. Microbiol. Biotechnol. 2003, 62, 195–206. [Google Scholar]
  74. Grande Burgos, M.J.; Pulido, R.P.; Del Carmen López Aguayo, M.; Gálvez, A.; Lucas, R. The cyclic antibacterial peptide enterocin AS-48: Isolation, mode of action, and possible food applications. Int. J. Mol. Sci. 2014, 15, 22706–22727. [Google Scholar] [CrossRef]
  75. Nissen-Meyer, J.; Rogne, P.; Oppegård, C.; Haugen, H.S.; Kristiansen, P.E. Structure-function relationships of the non-lanthionine-containing peptide (class II) bacteriocins produced by gram-positive bacteria. Curr. Pharm. Biotechnol. 2009, 10, 19–37. [Google Scholar] [CrossRef] [PubMed]
  76. Gálvez, A.; Abriouel, H.; López, R.L.; Ben Omar, N. Bacteriocin-based strategies for food biopreservation. Int. J. Food Microbiol. 2007, 120, 51–70. [Google Scholar] [CrossRef] [PubMed]
  77. Yildirim, Z.; Bilgin, H.; Isleroglu, H.; Tokatli, K.; Sahingil, D.; Yildirim, Z. Enterocin HZ produced by a wild Enterococcus faecium strain isolated from a traditional, starter-free pickled cheese. J. Dairy Res. 2014, 81, 164–172. [Google Scholar] [CrossRef]
  78. Jack, R.W.; Tagg, J.R.; Ray, B. Bacteriocins of gram-positive bacteria. Microbiol. Rev. 1995, 59, 171–200. [Google Scholar] [CrossRef]
  79. Sip, A.; Więckowicz, M.; Krasowska, M. Charakterystyka listeriobójczych bakteriocyn klasy IIa bakterii fermentacji mlekowej. Biotechnologia 2009, 3, 271–285. [Google Scholar]
  80. Sun, Z.; Wang, X.; Zhang, X.; Wu, H.; Zou, Y.; Li, P.; Sun, C.; Xu, W.; Liu, F.; Wang, D. Class III bacteriocin helveticin-M causes sublethal damage to target cells through impairment of cell wall and membrane. J. Ind. Microbiol. Biotechnol. 2018, 45, 213–227. [Google Scholar] [CrossRef]
  81. Schillinger, U.; Geisen, R.; Holzapfel, W.H. Potential of antagonistic microorganisms and bacteriocins for the biological preservation of foods. Trends Food Sci. Technol. 1996, 7, 158–164. [Google Scholar] [CrossRef]
  82. Tymoszewska, A.; Aleksandrzak-Piekarczyk, T. Studies on the mechanisms of action and development of resistance to class II bacteriocins of Gram-positive bacteria—Badania nad mechanizmami działania i rozwoju oporności na bakteriocyny klasy II u bakterii Gram-dodatnich. Postępy Biochem. 2024, 70, 266–278. [Google Scholar] [CrossRef] [PubMed]
  83. Kumariya, R.; Garsa, A.K.; Rajput, Y.S.; Sood, S.K.; Akhtar, N.; Patel, S. Bacteriocins: Classification, synthesis, mechanism of action and resistance development in food spoilage causing bacteria. Microb. Pathog. 2019, 128, 17. [Google Scholar] [CrossRef]
  84. Diep, D.B.; Skaugen, M.; Salehian, Z.; Holo, H.; Nes, I.F. Common mechanisms of target cell recognition and immunity for class II bacteriocins. Proc. Natl. Acad. Sci. USA 2007, 104, 2384–2389. [Google Scholar] [CrossRef]
  85. Breukink, E.; Wiedemann, I.; van Kraaij, C.; Kuipers, O.P.; Sahl, H.G.; de Kruijff, B. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 1999, 286, 2361–2364. [Google Scholar] [CrossRef] [PubMed]
  86. Kostrzynska, M.; Bachand, A. Application of DNA microarray technology for detection, identification, and characterization of food-borne pathogens. Can. J. Microbiol. 2006, 52, 1–8. [Google Scholar] [CrossRef] [PubMed]
  87. Baccus-Taylor, G.; Glass, K.A.; Luchansky, J.B.; Maurer, A.J. Fate of Listeria monocytogenes and pediococcal starter cultures during the manufacture of chicken summer sausage. Poult. Sci. 1993, 72, 1772–1778. [Google Scholar] [CrossRef] [PubMed]
  88. Rodríguez, E.; Calzada, J.; Arqués, J.L.; Rodríguez, J.M.; Nuñez, M.; Medina, M. Antimicrobial activity of pediocin-producing Lactococcus lactis on Listeria monocytogenes, Staphylococcus aureus, and Escherichia coli O157:H7 in cheese. Int. Dairy J. 2005, 15, 51–57. [Google Scholar] [CrossRef]
  89. Duffes, F.; Corre, C.; Leroi, F.; Dousset, X.; Boyaval, P. Inhibition of Listeria monocytogenes by in situ produced and semipurified bacteriocins of Carnobacterium spp. on vacuum-packed, refrigerated cold-smoked salmon. J. Food Prot. 1999, 62, 1394–1403. [Google Scholar] [CrossRef] [PubMed]
  90. Katla, T.; Møretrø, T.; Sveen, I.; Aasen, I.M.; Axelsson, L.; Rørvik, L.M.; Naterstad, K. Inhibition of Listeria monocytogenes in chicken cold cuts by addition of sakacin P and sakacin P-producing Lactobacillus sakei. J. Appl. Microbiol. 2002, 93, 191–196. [Google Scholar] [CrossRef] [PubMed]
  91. Aasen, I.M.; Markussen, S.; Møretrø, T.; Katla, T.; Axelsson, L.; Naterstad, K. Interactions of the bacteriocins sakacin P and nisin with food constituents. Int. J. Food Microbiol. 2003, 87, 35–43. [Google Scholar] [CrossRef]
  92. Aymerich, T.; Artigas, M.G.; Garriga, M.; Monfort, J.M.; Hugas, M. Effect of sausage ingredients and additives on the production of enterocin A and B by Enterococcus faecium CTC492. Optimization of in vitro production and anti-listerial effect in dry fermented sausages. J. Appl. Microbiol. 2000, 88, 686–694. [Google Scholar] [CrossRef]
  93. Deegan, L.H.; Cotter, P.D.; Hill, C.; Ross, P. Bacteriocins: Biological tools for bio-preservation and shelf-life extension. Int. Dairy J. 2006, 16, 1058–1071. [Google Scholar] [CrossRef]
  94. Settanni, L.; Corsetti, A. Application of bacteriocins in vegetable food biopreservation. Int. J. Food Microbiol. 2008, 121, 123–138. [Google Scholar] [CrossRef] [PubMed]
  95. Benítez-Chao, D.F.; León-Buitimea, A.; Lerma-Escalera, J.A.; Morones-Ramírez, J.R. Bacteriocins: An overview of antimicrobial, toxicity, and biosafety assessment by in vivo models. Front. Microbiol. 2021, 12, 630695. [Google Scholar] [CrossRef] [PubMed]
  96. Soltani, S.; Hammami, R.; Cotter, P.D.; Rebuffat, S.; Said, L.B.; Gaudreau, H.; Bédard, F.; Biron, E.; Drider, D.; Fliss, I. Bacteriocins as a new generation of antimicrobials: Toxicity aspects and regulations. FEMS Microbiol. Rev. 2021, 45, 039. [Google Scholar] [CrossRef]
  97. Cotter, P.D.; Ross, R.P.; Hill, C. Bacteriocins—A viable alternative to antibiotics? Nat. Rev. Microbiol. 2013, 11, 95–105. [Google Scholar] [CrossRef] [PubMed]
  98. Gravesen, A.; Kallipolitis, B.; Holmstrøm, K.; Høiby, P.E.; Ramnath, M.; Knøchel, S. pbp2229-mediated nisin resistance mechanism in Listeria monocytogenes confers cross-protection to class IIa bacteriocins and affects virulence gene expression. Appl. Environ. Microbiol. 2004, 70, 1669–1679. [Google Scholar] [CrossRef]
  99. De Martinis, E.C.P.; Crandall, A.D.; Mazzotta, A.S.; Montville, T.J. Influence of pH, salt, and temperature on nisin resistance in Listeria monocytogenes. J. Food Prot. 1997, 60, 420–423. [Google Scholar] [CrossRef]
  100. Collins, B.; Joyce, S.; Hill, C.; Cotter, P.D.; Ross, R.P. TelA contributes to the innate resistance of Listeria monocytogenes to nisin and other cell wall-acting antibiotics. Antimicrob. Agents Chemother. 2010, 54, 4658–4663. [Google Scholar] [CrossRef]
  101. Collins, B.; Guinane, C.M.; Cotter, P.D.; Hill, C.; Ross, R.P. Assessing the contributions of the LiaS histidine kinase to the innate resistance of Listeria monocytogenes to nisin, cephalosporins, and disinfectants. Appl. Environ. Microbiol. 2012, 78, 2923–2929. [Google Scholar] [CrossRef]
  102. Tessema, G.T.; Møretrø, T.; Snipen, L.; Axelsson, L.; Naterstad, K. Global transcriptional analysis of spontaneous sakacin P-resistant mutant strains of Listeria monocytogenes during growth on different sugars. PLoS ONE 2011, 6, 16192. [Google Scholar] [CrossRef] [PubMed]
  103. Vadyvaloo, V.; Arous, S.; Gravesen, A.; Héchard, Y.; Chauhan-Haubrock, R.; Hastings, J.W.; Rautenbach, M. Cell-surface alterations in class IIa bacteriocin-resistant Listeria monocytogenes strains. Microbiology 2004, 150, 3025–3033. [Google Scholar] [CrossRef] [PubMed]
  104. Verheul, A.; Russell, N.J.; Van’THof, R.; Rombouts, F.M.; Abee, T. Modifications of membrane phospholipid composition in nisin-resistant Listeria monocytogenes Scott A. Appl. Environ. Microbiol. 1997, 63, 3451–3457. [Google Scholar] [CrossRef] [PubMed]
  105. Abee, T.; Rombouts, F.M.; Hugenholtz, J.; Guihard, G.; Letellier, L. Mode of action of nisin Z against Listeria monocytogenes Scott A grown at high and low temperatures. Appl. Environ. Microbiol. 1994, 60, 1962–1968. [Google Scholar] [CrossRef] [PubMed]
  106. Stincone, P.; Fonseca Veras, F.; Micalizzi, G.; Donnarumma, D.; Vitale Celano, G.; Petras, D.; de Angelis, M.; Mondello, L.; Brandelli, A. Listeria monocytogenes exposed to antimicrobial peptides display differential regulation of lipids and proteins associated to stress response. Cell. Mol. Life Sci. 2022, 79, 263. [Google Scholar] [CrossRef] [PubMed]
  107. Robichon, D.; Gouin, E.; Débarbouille, M.; Cossart, P.; Cenatiempo, Y.; Héchard, Y. The rpoN (σ54) gene from Listeria monocytogenes is involved in resistance to mesentericin Y105, an antibacterial peptide from Leuconostoc mesenteroides. J. Bacteriol. 1997, 179, 7591–7594. [Google Scholar] [CrossRef] [PubMed]
  108. Gravesen, A.; Ramnath, M.; Rechinger, K.B.; Andersen, N.; Jansch, L.; Héchard, Y.; Hastings, J.W.; Knøchel, S. High-level resistance to class IIa bacteriocins is associated with one general mechanism in Listeria monocytogenes. Microbiology 2002, 148, 2361–2369. [Google Scholar] [CrossRef] [PubMed]
  109. Mandin, P.; Fsihi, H.; Dussurget, O.; Vergassola, M.; Milohanic, E.; Toledo-Arana, A.; Lasa, I.; Johansson, J.; Cossart, P. VirR, a response regulator critical for Listeria monocytogenes virulence. Mol. Microbiol. 2005, 57, 1367–1380. [Google Scholar] [CrossRef] [PubMed]
  110. Bergholz, T.M.; Tang, S.; Wiedmann, M.; Boor, K.J. Nisin resistance of Listeria monocytogenes is increased by exposure to salt stress and is mediated via LiaR. Appl. Environ. Microbiol. 2013, 79, 5682–5688. [Google Scholar] [CrossRef]
  111. Bastos, M.d.o.C.; Coelho, M.L.; Santos, O.C. Resistance to bacteriocins produced by Gram-positive bacteria. Microbiology 2015, 161, 683–700. [Google Scholar] [CrossRef] [PubMed]
  112. Dalet, K.; Cenatiempo, Y.; Cossart, P.; Héchard, Y.; European Listeria Genome Consortium. A σ54-dependent PTS permease of the mannose family is responsible for sensitivity of Listeria monocytogenes to mesentericin Y105. Microbiology 2001, 147, 3263–3269. [Google Scholar] [CrossRef] [PubMed]
  113. Gravesen, A.; Sorensen, K.; Aarestrup, F.M.; Knochel, S. Spontaneous nisin-resistant Listeria monocytogenes mutants with increased expression of a putative penicillin-binding protein and their sensitivity to various antibiotics. Microb. Drug Resist. 2001, 7, 127–135. [Google Scholar] [CrossRef] [PubMed]
  114. Ramnath, M.; Beukes, M.; Tamura, K.; Hastings, J.W. Absence of a putative mannose-specific phosphotransferase system enzyme IIAB component in a leucocin A-resistant strain of Listeria monocytogenes, as shown by two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Appl. Environ. Microbiol. 2000, 66, 3098–3101. [Google Scholar] [CrossRef] [PubMed]
  115. Abachin, E.; Poyart, C.; Pellegrini, E.; Milohanic, E.; Fiedler, F.; Berche, P.; Trieu-Cuot, P. Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol. Microbiol. 2002, 43, 1–14. [Google Scholar] [CrossRef]
  116. Khatib, T.O.; Stevenson, H.; Yeaman, M.R.; Bayer, A.S.; Pokorny, A. Binding of daptomycin to anionic lipid vesicles is reduced in the presence of lysyl-phosphatidylglycerol. Antimicrob. Agents Chemother. 2016, 60, 5051–5053. [Google Scholar] [CrossRef] [PubMed]
  117. Vadyvaloo, V.; Hastings, J.W.; van der Merwe, M.J.; Rautenbach, M. Membranes of class IIa bacteriocin-resistant Listeria monocytogenes cells contain increased levels of desaturated and short-acyl-chain phosphatidylglycerols. Appl. Environ. Microbiol. 2002, 68, 5223–5230. [Google Scholar] [CrossRef]
  118. Daeschel, M.A.; Ming, X. Correlation of cellular phospholipids content with nisin resistance of Listeria monocytogenes Scott A. J. Food Prot. 1995, 58, 416–420. [Google Scholar]
  119. Crandall, A.D.; Montville, T.J. Nisin resistance in Listeria monocytogenes ATCC 700302 is a complex phenotype. Appl. Environ. Microbiol. 1998, 64, 231–237. [Google Scholar] [CrossRef] [PubMed]
  120. Thedieck, K.; Hain, T.; Mohamed, W.; Tindall, B.J.; Nimtz, M.; Chakraborty, T.; Wehland, J.; Jänsch, L. The MprF protein is required for lysinylation of phospholipids in listerial membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on Listeria monocytogenes. Mol. Microbiol. 2006, 62, 1325–1339. [Google Scholar] [CrossRef] [PubMed]
  121. Collins, B.; Curtis, N.; Cotter, P.D.; Hill, C.; Ross, R.P. The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various β-lactam antibiotics. Antimicrob. Agents Chemother. 2010, 54, 4416–4423. [Google Scholar] [CrossRef] [PubMed]
  122. Grubaugh, D.; Regeimbal, J.M.; Ghosh, P.; Zhou, Y.; Lauer, P.; Dubensky Jr, T.W.; Higgins, D.E. The VirAB ABC transporter is required for VirR regulation of Listeria monocytogenes virulence and resistance to nisin. Infect. Immun. 2018, 86, 901–917. [Google Scholar] [CrossRef]
  123. Cotter, P.D.; Guinane, C.M.; Hill, C. The LisRK signal transduction system determines the sensitivity of Listeria monocytogenes to nisin and cephalosporins. Antimicrob. Agents Chemother. 2002, 46, 2784–2790. [Google Scholar] [CrossRef]
  124. Abee, T.; van Schaik, W.; Siezen, R.J. Impact of genomics on microbial food safety. Trends Biotechnol. 2004, 22, 653–660. [Google Scholar] [CrossRef] [PubMed]
  125. Kaur, G.; Singh, T.P.; Malik, R.K.; Bhardwaj, A. Mechanism of nisin, pediocin 34, and enterocin FH99 resistance in Listeria monocytogenes. Probiotics Antimicrob. Proteins 2012, 4, 11–20. [Google Scholar] [CrossRef] [PubMed]
  126. Liu, S.; Liu, Y.; Zhang, P. Properties of Listeria monocytogenes on acquisition of pediocin resistance. Ann. Microbiol. 2019, 69, 123–130. [Google Scholar] [CrossRef]
  127. Martínez, B.; Rodríguez, A. Antimicrobial susceptibility of nisin-resistant Listeria monocytogenes of dairy origin. FEMS Microbiol. Lett. 2005, 252, 67–72. [Google Scholar] [CrossRef] [PubMed]
  128. Begley, M.; Cotter, P.D.; Hill, C.; Ross, R.P. Glutamate decarboxylase-mediated nisin resistance in Listeria monocytogenes. Appl. Environ. Microbiol. 2010, 76, 6541–6546. [Google Scholar] [CrossRef] [PubMed]
  129. Jydegaard, A.M.; Gravesen, A.; Knøchel, S. Growth condition-related response of Listeria monocytogenes 412 to bacteriocin inactivation. Lett. Appl. Microbiol. 2000, 31, 68–72. [Google Scholar] [CrossRef] [PubMed]
  130. Cole, M.B.; Jones, M.V.; Holyoak, C. The effect of pH, salt concentration, and temperature on the survival and growth of Listeria monocytogenes. J. Appl. Bacteriol. 1990, 69, 63–72. [Google Scholar] [CrossRef] [PubMed]
  131. Rasch, M.; Knøchel, S. Variations in tolerance of Listeria monocytogenes to nisin, pediocin PA-1, and bavaricin A. Lett. Appl. Microbiol. 1998, 27, 275–278. [Google Scholar] [CrossRef]
  132. Liu, G.; Nie, R.; Liu, Y.; Mehmood, A. Combined Antimicrobial Effect of Bacteriocins with Other Hurdles of Physicochemic and Microbiome to Prolong Shelf Life of Food: A Review. Sci. Total Environ. 2022, 825, 154058. [Google Scholar] [CrossRef]
  133. Mazzotta, A.S.; Montville, T.J. Nisin induces changes in membrane fatty acid composition of Listeria monocytogenes nisin-resistant strains at 10 degrees C and 30 degrees C. J. Appl. Microbiol. 1997, 82, 32–38. [Google Scholar] [CrossRef]
  134. Cotter, P.D.; Ryan, S.; Gahan, C.G.M.; Hill, C. The presence of GadD1 glutamate decarboxylase in selected Listeria monocytogenes strains is associated with an ability to grow at low pH. Appl. Environ. Microbiol. 2005, 71, 2832–2839. [Google Scholar] [CrossRef]
  135. Parente, E.; Giglio, M.A.; Ricciardi, A.; Clementi, F. The combined effect of nisin, leucocin F10, pH, NaCl, and EDTA on the survival of Listeria monocytogenes in broth. Int. J. Food Microbiol. 1998, 40, 65–75. [Google Scholar] [CrossRef]
  136. Meade, E.; Slattery, M.A.; Garvey, M. Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile? Antibiotics 2020, 9, 32. [Google Scholar] [CrossRef] [PubMed]
  137. Ismael, M.; Huang, M.; Zhong, Q. The Bacteriocins Produced by Lactic Acid Bacteria and the Promising Applications in Promoting Gastrointestinal Health. Foods 2024, 13, 3887. [Google Scholar] [CrossRef] [PubMed]
  138. Begley, M.; Hill, C.; Ross, R.P. Tolerance of Listeria monocytogenes to cell envelope-acting antimicrobial agents is dependent on SigB. Appl. Environ. Microbiol. 2003, 72, 2231–2234. [Google Scholar] [CrossRef]
  139. Gradisteanu Pircalabioru, G.; Popa, L.I.; Marutescu, L.; Gheorghe, I.; Popa, M.; Czobor Barbu, I.; Cristescu, R.; Chifiriuc, M.C. Bacteriocins in the Era of Antibiotic Resistance: Rising to the Challenge. Pharmaceutics 2021, 13, 196. [Google Scholar] [CrossRef]
Table 1. Classification of bacteriocins.
Table 1. Classification of bacteriocins.
ClassFeaturesExamples, ProducersMechanisms of ActionReceptorsReferences
ILantibiotics (<5 kDa) peptides containing lanthionine and
methyllanthionine
Nisin (Lactococcus lactis)Membrane permeabilization by pore formation and disrupting of cell wall synthesisLipid II[74]
IIaSmall (<10 kDa), heat-stable peptides with broad-spectrum activity against Listeria spp.Pediocin PA-1 (Pediococcus acidilactici), sakacin A (Latilactobacillus sakei)Membrane
permeabilization by pore formation
Mannose permease (Man-PTS)[73]
IIbTwo-component bacteriocin: two different peptides required to form an active poration complexPlantaricin JK (Lactiplantibacillus plantarum)Membrane permeabilization by pore formationUppP (undecaprenyl pyrophosphate phosphatase)[75]
IIcCircular bacteriocinsEnterocin AS-48 (Enterococcus faecalis)Membrane permeabilization by pore formationABC transporter[76]
IIILarge protein (>30 kDa), heat-sensitive; limited application due to instabilityHelveticin J (Lactobacillus helveticus)Cell wall lysis through hydrolysisGlycopeptides in cell wall[77]
Table 2. The main mechanisms and genetic determinants associated with L. monocytogenes resistance to LAB bacteriocins.
Table 2. The main mechanisms and genetic determinants associated with L. monocytogenes resistance to LAB bacteriocins.
Type of ModificationMechanismsGenetic DeterminantsReferences
Changes in receptorsShielding lipid IIpbp2229[98]
Mutational change in receptor structuremptACD operon[61]
Cell wall modificationIncreased positive charges in cell wall-D-alanylation of teichoic acid or lipoteichoic aciddlt operon[103]
lmo1967 locus (homologue to telA)[100]
Cell membrane modificationChanges in membrane fatty acid compositionmprF[103,104]
Increase in L-lysine content of membrane phospholipids
Divalent and trivalent cations stabilize the cytoplasmic membraneN/A[105]
Change in membrane fluiditylmo2552 and lmo1539[106]
Regulatory networksRegulation of mptACD operonσB[106]
rpoN[107]
manR[108]
Two-component systemsAdaptation to the presence of bacteriocinsVirRS[109]
AnrAB[100]
LisRK[110]
LiaFSK[110]
N/A—not applicable.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zawiasa, A.; Olejnik-Schmidt, A. The Genetic Determinants of Listeria monocytogenes Resistance to Bacteriocins Produced by Lactic Acid Bacteria. Genes 2025, 16, 50. https://doi.org/10.3390/genes16010050

AMA Style

Zawiasa A, Olejnik-Schmidt A. The Genetic Determinants of Listeria monocytogenes Resistance to Bacteriocins Produced by Lactic Acid Bacteria. Genes. 2025; 16(1):50. https://doi.org/10.3390/genes16010050

Chicago/Turabian Style

Zawiasa, Anna, and Agnieszka Olejnik-Schmidt. 2025. "The Genetic Determinants of Listeria monocytogenes Resistance to Bacteriocins Produced by Lactic Acid Bacteria" Genes 16, no. 1: 50. https://doi.org/10.3390/genes16010050

APA Style

Zawiasa, A., & Olejnik-Schmidt, A. (2025). The Genetic Determinants of Listeria monocytogenes Resistance to Bacteriocins Produced by Lactic Acid Bacteria. Genes, 16(1), 50. https://doi.org/10.3390/genes16010050

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop